Altered gene expression in striatal projection neurons in CB 1 cannabinoid receptor knockout mice
H. Steiner,T. Bonner,A. Zimmer,S. Kitai,A. Zimmer
Abstract:The basal ganglia, a brain structure critical for sensorimotor and motivational aspects of behavior, contain very high levels of CB1 cannabinoid receptors. These receptors are activated by endogenous lipophilic ligands, and they are thought to mediate behavioral effects of cannabinoid drugs. To evaluate the role of the endogenous cannabinoid system in the regulation of basal ganglia pathways, we have investigated the effects of targeted deletion of CB1 receptors on gene expression of various neuropeptides and transmitterrelated enzymes in basal ganglia neurons. Mice without CB1 receptors are extremely hypoactive in a test for exploratory behavior (open-field test), showing markedly reduced locomotion and rearing. These CB1 mutants display significantly increased levels of substance P, dynorphin, enkephalin, and GAD 67 mRNAs in neurons of the two output pathways of the striatum that project to the substantia nigra and the globus pallidus. Our findings demonstrate that elimination of CB1 receptors results in behavioral abnormalities and functional reorganization of the basal ganglia. Cannabinoid drugs have various cognitive and behavioral effects, including euphoria, memory impairment, ataxia, and sedation, but they also seem to be useful as therapeutic agents, for example, in the treatment of nausea, glaucoma, chronic pain, and epilepsy (1). These pharmacological effects are thought to be mediated by the CB1 cannabinoid receptor subtype (2–4). However, the normal role of the CB1 receptor and its endogenous ligands (5–8) in brain function and behavior remains largely unknown. We have used targeted elimination of the CB1 receptor (34) to investigate the function of the endogenous cannabinoid system. The basal ganglia are among the brain structures with the highest levels of CB1 receptors (9–13). In the present study, we examined effects of CB1 receptor deletion on basal ganglia circuits and spontaneous motor behavior. In the basal ganglia, CB1 receptors are expressed predominantly in neurons of the striatum that give rise to the two output pathways, one to the substantia nigra and the other to the globus pallidus (11–13). Both pathways use g-aminobutyric acid (GABA) as their principal neurotransmitter (14), but they differ in neuropeptide cotransmitters. Striatonigral neurons, the so-called ‘‘direct’’ pathway, mostly express the neuropeptides substance P and dynorphin, whereas striatopallidal neurons, the initial segment of the ‘‘indirect’’ pathway, generally contain enkephalin (15). To assess whether striatal projection neurons are affected by disruption of the CB1 receptor, we investigated the expression of these neuropeptides and the GABA synthetic enzyme GAD 67 with quantitative in situ hybridization histochemistry. Dopamine neurons in the substantia nigra and ventral tegmental area provide important afferents to the dorsal and ventral striatum and, in turn, receive inputs from these striatal regions. Although dopamine neurons do not appear to express CB1 receptors (11–13), recent results showed that cannabinoid agonists increase the firing rate of dopamine neurons (16, 17). Moreover, perinatal cannabinoid treatment was reported to affect the expression of the dopamine synthetic enzyme tyrosine hydroxylase in dopamine neurons (18). We thus also examined tyrosine hydroxylase expression in the substantia nigrayventral tegmental area. MATERIALS AND METHODS Generation of CB1 Receptor-Deficient Mice. CB1 mutants were generated as described (34). Briefly, the coding region of the CB1 gene was replaced between amino acids 32 and 448 with PGK-neo in embryonic stem cells. Chimeric mice derived from these cells were bred with C57BLy6J animals. Homozygous mutants (CB12y2) and wild-type (CB11y1) mice were produced with heterozygous intermatings. In these experiments, 12to 20-week-old male and female mice were used. Animals were housed in groups under standard laboratory conditions (12-hr-lighty12-hr-dark cycle) with food and water available ad libitum. Open-Field Test. An automated open-field system was used (box size, 27 3 27 cm; ENV-510; MED Associates, St. Albans, VT). Mice (CB11y1, n 5 11; CB12y2, n 5 8) were placed individually into the central area of the open field, and behaviors were recorded and analyzed from minutes 2 to 42. Ambulatory activity, local movements, and rearing events were assessed by using the ACTIVITY 3.01 software. Rotarod Test. The rotarod test was performed by using an accelerating rotarod (4–40 rpm; Ugo Basile, Varese, Italy). Animals (CB11y1, n 5 9; CB12y2, n 5 11) were tested in three trials with 30-min intervals. Cut-off time was 5 min. In Situ Hybridization Histochemistry. Mice (n 5 7, each genotype) were killed with CO2. The brains were removed rapidly and processed as described (19). Coronal sections (12 mm) were hybridized with 35S-labeled oligonucleotide probes (for substance P, complementary to bases 20–67, GenBank accession no. M68909; enkephalin, bases 304–351, M13227; dynorphin, bases 807–854, AF026537; GAD 67, bases 465–512, Y12257; tyrosine hydroxylase, bases 1435–1482, M69200; CB1, bases 1081–1128, U22948). The slide-mounted sections were apposed to x-ray film (Biomax MR; Kodak) for 3–11 days. Measurement of Gene Expression. Hybridization signals on film autoradiograms were measured with densitometry by using the public domain NIH IMAGE program (developed by Wayne Rasband at the National Institutes of Health and available on the Internet at http:yyrsb.info.nih.govynihimage). CB1, neuropeptide, and GAD 67 expression were analyzed in the following 11 areas: nucleus accumbens core and shell, at approximately 1.5 mm rostral to bregma (20); The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked ‘‘advertisement’’ in accordance with 18 U.S.C. §1734 solely to indicate this fact. PNAS is available online at www.pnas.org. A Commentary on this article begins on page 5338. ‡To whom reprint requests should be addressed. e-mail: zimmer@ codon.nih.gov.